Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
This study is currently recruiting participants.
Study NCT00319982   Information provided by Brigham and Women's Hospital
First Received: April 27, 2006   Last Updated: September 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertrophic Cardiomyopathy
Additional conditions recognized in this trial
Cardiomyopathies
Cardiomyopathy, Hypertrophic
Hypertrophy
More general conditions related to this trial
Aortic Stenosis, Subvalvular
Aortic Valve Stenosis
Cardiovascular Diseases
Heart Diseases
Heart Valve Diseases
Pathological Conditions, Anatomical
Interventions listed in this trial
Diltiazem
Placebo
Additional drug interventions recognized in this trial
Verapamil
More general drug interventions related to this trial
Anti-Arrhythmia Agents
Antihypertensive Agents
Calcium Channel Blockers
Cardiovascular Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI)
Children's Hospital Boston


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services